Merck veteran launches immuno-oncology startup with $80M

After more than six years heading up oncology units at Merck & Co. Inc., Zhen Su is leading his own startup to expand into the immuno-oncology space.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.